Xin Lang Cai Jing·2025-12-19 10:24Core Viewpoint - The transaction of control rights in Sichuang Medical Technology involves the general manager Wei Naixu achieving MBO through a "share transfer + voting rights" model. The company previously attempted to sell to state-owned assets but was terminated due to non-compliance with relevant state-owned asset regulations. Notably, state-owned assets are indirectly involved in the MBO process [1][6][8]. Group 1: Control Rights Transactions - As of December 15, over 170 listed companies have undergone changes in actual controllers, with methods including agreement transfers, voting rights entrustment, and judicial auctions [1]. - The "small shareholding + voting rights entrustment" model is frequently used in control rights transactions, as seen in companies like Guao Technology and ST Zhiyun [2][14]. Group 2: Advantages of the New Transaction Model - The "small shareholding + voting rights entrustment" model allows acquirers to achieve control at a minimal cost, providing significant leverage and reducing premium payments [4][16]. - This model can facilitate control transfer for sellers facing restrictions on share freezing or reduction, enhancing transaction efficiency by avoiding mandatory tender offer obligations [4][16]. Group 3: Case Study of Sichuang Medical Technology - In the control rights transaction, Wei Naixu acquired 5.61% of shares through a transfer agreement priced at 2.872 yuan per share, totaling 180 million yuan [6][17]. - After the transaction, Wei Naixu indirectly held 7.47% of shares and controlled 13.18% of voting rights, making him the actual controller of Sichuang Medical Technology [7][18]. Group 4: Historical Issues and Risks - Sichuang Medical Technology has faced regulatory penalties for financial fraud, including inflated revenues and profits in previous years, leading to significant fines and market bans for executives [11][22]. - The company is currently under investigation for fraudulent issuance, with ongoing legal scrutiny affecting its stock performance [12][23].